Home > Press > MEMS and Nanotechnology Providing Real Solutions for the Management of Diabetes
MEMS and Nanotechnology Providing Real Solutions for the Management of Diabetes
Scottsdale, AZ | Posted on July 11, 2006
During the first half of 2006 there was a noticeable upswing in activity focused on the development of MEMS (MicroElectroMechanical Systems) and Nanotechnology-based solutions for the care and management of Diabetes, according to Bourne Research. The market research firm reports that a variety of MEMS devices, nanostructures and other emerging technologies are not only being tapped for blood glucose monitoring and insulin delivery, but for other Diabetes-related complications as well, including those related to the eyes and gastrointestinal tract.
“What’s most notable about the current round of products in development, in clinical trials, or recently approved by the FDA and launched into the market is that many are wireless, implantable or both,” says Marlene Bourne, President & Principal Analyst with Bourne Research. “While these approaches will make living with and managing Diabetes much easier, they are also highlighting a very real need for next-generation battery technologies, which are in development.”
Bourne Research reports that even though a few large firms dominate the Diabetes market, it remains very attractive for start-ups with innovative ideas, since this segment has historically been at the forefront of acquisition activity. The firm notes that five companies have received nearly $80 million in venture capital funding in the past few months, and an acquisition is pending.
More details about the use of MEMS and Nanotechnology for the management of Diabetes can be found in The Bourne Report – Medical Device Quarterly, a report series written especially for those interested in BioMEMS and Nanomedicine. The Bourne Report offers the most insightful analysis available on emerging technologies, with a focus on MEMS and Nanotechnology. To subscribe to The Bourne Report, or for more information about Bourne Research, please visit: www.bourneresearch.com or contact Marlene Bourne at 480-695-0521 or email@example.com.
About Bourne Research:
Bourne Research is a trusted source of market intelligence, with a specialized focus on MEMS (MicroElectroMechanical Systems), Nanotechnology, and the convergence of both. Its founder, Marlene Bourne, is a highly respected industry analyst with more than a decade of experience following the development of emerging technologies, and is internationally recognized as one of the leading experts on MEMS.
For more information, please click here.
President & Principal Analyst
Bourne Research LLC
8867 E. Mountain Spring Rd
Scottsdale, AZ 85255
Copyright © Bourne Research
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Silex Microsystems Joins ENIAC Project PROMINENT To Bring Flexible and Cost Effective Inkjet Technologies to the MEMS Manufacturing Process: Silex Will Develop New Solutions for Through-Silicon Via Manufacture and Hermetic Wafer Bonding May 13th, 2013
memsstar Appoints Tony McKie as CEO to Drive Expansion In Semiconductor and MEMS Markets April 10th, 2013
mPhase to Publically Display the mPower Jump at NJTC Venture Conference on March 22, 2013 March 8th, 2013
Robert Bosch GmbH places order for SolMateS' Pulsed Laser Deposition system March 1st, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Nanoparticle Delivers Large Protein Complex to Cancer Cell Nucleus May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013